1. Combination ART Regimens
- Standard treatment mixes three or more antiretroviral drugs across two or more classes—such as integrase strand transfer inhibitors (INSTIs), nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), or protease inhibitors—often in a single daily pill format
- Common regimens include Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide)—widely used as first-line therapy due to its efficacy, tolerability, and simplicity.
2. Long-Acting Injectable ART
- For patients needing alternatives to daily pills, lenacapavir (Sunlenca) offers an injectable option administered every six months, a first-of-its-kind convenience for treatment-experienced individuals.
- This can help improve adherence and simplify care for those facing pill fatigue or adherence challenges.